First things first, why does Capire360 exist?
Capire360 was created to complement the knowledge and expertise of oncologists by providing evidence-based insight on treatment options based on real-word data. This was needed because clinical trial data is based on the results of patients who are on average, healthier, younger, and less diverse, Capire360’s real-world data approach augments clinical trial data with data that is representative of the population at large, not just the small number selected to participate in trials.
Our parent company, PotentiaMetrics, maintains one of the largest databases of real-world outcomes, which powers Capire360. Our data is clinical registry data derived from over 500 medical centers, encompassing over 2-million cancer patients – offering more accurate and relevant outcomes information.
This information coupled with discussions with a MyCancerJourney advocate enables true shared decision-making between the member and their oncology care team.
Who is Capire360 applicable to?
Capire360 is specifically relevant to patients with a new cancer diagnosis. It provides insight into the treatment outcomes of “people like you” for the guideline choices established by the NCCN (National Comprehensive Cancer Network) for the member’s type and stage of cancer.
If a member has a new cancer diagnosis, they can provide their MyCancerJourney advocate the relevant information about themselves: their age, sex, race/ethnicity, any pre-existing health conditions, and about their cancer diagnosis. Then, they can share detailed information that can help answer questions based on the experiences of other people like them. For example, what are all the treatment options for my type of cancer? Have certain treatments proven to be more effective than others? Is chemotherapy worth the associated side effects?
With this information, they can make decisions that best align with what matters most to them, based on insights meaningful to them. After all, every patient’s journey is unique, and there is no one-size-fits-all solution.
Data You Can Trust
PotentiaMetrics spent a decade developing and testing Capire360 within top medical schools. The statistical models that power Capire360 are tested internally and externally, ensuring they accurately reflect survival outcomes.
Experts in healthcare analytics from the Erasmus University Medical Center, including Professor Ewout Steyerberg, one of the world’s top specialists in medical decision-making and prognostic modeling, have validated the models and their methodology.
Capire360 is updated annually, continuously reviewed by oncologists, and compared to data from the National Cancer Institute’s SEER database to ensure accuracy and confirm clinical value.
Experts in healthcare analytics from the Erasmus University Medical Center, including Professor Ewout Steyerberg, one of the world’s top specialists in medical decision-making and prognostic modeling, have validated the models and their methodology.
Capire360 is updated annually, continuously reviewed by oncologists, and compared to data from the National Cancer Institute’s SEER database to ensure accuracy and confirm clinical value.
Partner with MyCancerJourney
Interested in learning what MyCancerJourney can do for your population? Request a demo and a representative will be in touch within one business day. Our business hours are Monday-Friday 8AM - 5PM CT.
Address
901 S. Mopac Expy.
Bldg. 1, Ste. 300
Austin, TX 78746
Bldg. 1, Ste. 300
Austin, TX 78746
Email us
info@mycancerjourney.com
Call us
737 307 0077